Literature DB >> 31152764

[18F]Fluciclovine-PET Guided Salvage Lymph Node Dissection Following Radical Prostatectomy.

Samuel J Galgano1, Carli E Calderone1, Jeffrey W Nix2, Soroush Rais-Bahrami3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31152764      PMCID： PMC8983103          DOI： 10.1016/j.urology.2019.05.022

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  25 in total

1.  First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches.

Authors:  Riccardo Schiavina; Sergio Concetti; Eugenio Brunocilla; Cristina Nanni; Marco Borghesi; Giorgio Gentile; Matteo Cevenini; Lorenzo Bianchi; Enrico Molinaroli; Stefano Fanti; Giuseppe Martorana
Journal:  Urol Int       Date:  2013-12-07       Impact factor: 2.089

2.  177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment.

Authors:  Madhav Prasad Yadav; Sanjana Ballal; Madhavi Tripathi; Nishikant Avinash Damle; Ranjit Kumar Sahoo; Amlesh Seth; Chandrasekhar Bal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-10       Impact factor: 9.236

3.  18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients.

Authors:  Kirsten M Selnæs; Brage Krüger-Stokke; Mattijs Elschot; Frode Willoch; Øystein Størkersen; Elise Sandsmark; Siver A Moestue; May-Britt Tessem; Dag Halvorsen; Eirik Kjøbli; Anders Angelsen; Sverre Langørgen; Helena Bertilsson; Tone F Bathen
Journal:  Eur Radiol       Date:  2018-01-02       Impact factor: 5.315

Review 4.  New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.

Authors:  Laura Evangelista; Alberto Briganti; Stefano Fanti; Stephen Joniau; Sven Reske; Riccardo Schiavina; Christian Stief; George N Thalmann; Maria Picchio
Journal:  Eur Urol       Date:  2016-02-02       Impact factor: 20.096

5.  The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.

Authors:  Gerald L Andriole; Lale Kostakoglu; Albert Chau; Fenghai Duan; Umar Mahmood; David A Mankoff; David M Schuster; Barry A Siegel
Journal:  J Urol       Date:  2019-02       Impact factor: 7.450

6.  Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

Authors:  David M Schuster; Peter T Nieh; Ashesh B Jani; Rianot Amzat; F Dubois Bowman; Raghuveer K Halkar; Viraj A Master; Jonathon A Nye; Oluwaseun A Odewole; Adeboye O Osunkoya; Bital Savir-Baruch; Pooneh Alaei-Taleghani; Mark M Goodman
Journal:  J Urol       Date:  2013-10-19       Impact factor: 7.450

7.  PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.

Authors:  Ann-Christin Baranski; Martin Schäfer; Ulrike Bauder-Wüst; Mareike Roscher; Jana Schmidt; Esther Stenau; Tobias Simpfendörfer; Dogu Teber; Lena Maier-Hein; Boris Hadaschik; Uwe Haberkorn; Matthias Eder; Klaus Kopka
Journal:  J Nucl Med       Date:  2017-11-30       Impact factor: 10.057

8.  Mapping of pelvic lymph node metastases in prostate cancer.

Authors:  Steven Joniau; Laura Van den Bergh; Evelyne Lerut; Christophe M Deroose; Karin Haustermans; Raymond Oyen; Tom Budiharto; Filip Ameye; Kris Bogaerts; Hein Van Poppel
Journal:  Eur Urol       Date:  2012-07-06       Impact factor: 20.096

9.  Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center.

Authors:  Samuel J Galgano; Carli E Calderone; Andrew M McDonald; Jeffrey W Nix; Mollie deShazo; Eddy S Yang; Jonathan E McConathy; Soroush Rais-Bahrami
Journal:  J Am Coll Radiol       Date:  2018-11-14       Impact factor: 5.532

10.  Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.

Authors:  Nicola Fossati; Nazareno Suardi; Giorgio Gandaglia; Carlo A Bravi; Matteo Soligo; R Jeffrey Karnes; Shahrokh Shariat; Antonino Battaglia; Wouter Everaerts; Steven Joniau; Hendrik Van Poppel; Nieroshan Rajarubendra; Inderbir S Gill; Alessandro Larcher; Alexander Mottrie; Maximilian Schmautz; Axel Heidenreich; Almut Kalz; Daniar Osmonov; Klaus-Peter Juenemann; Annika Herlemann; Christian Gratzke; Christian Stief; Francesco Montorsi; Alberto Briganti
Journal:  Eur Urol       Date:  2018-10-06       Impact factor: 24.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.